Related references
Note: Only part of the references are listed.Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system
Ying Xu et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Effect of Adenosine A2A Receptor Antagonists on l-DOPA-Induced Hydroxyl Radical Formation in Rat Striatum
Krystyna Golembiowska et al.
NEUROTOXICITY RESEARCH (2009)
Dual inhibition of monoamine oxidase B and antagonism of the adenosine A2A receptor by (E,E)-8-(4-phenylbutadien-1-yl)caffeine analogues
Judey Pretorius et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
New pyrrole inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity
Giuseppe La Regina et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Inhibition of monoamine oxidase B by selected benzimidazole and caffeine analogues
Deidre van den Berg et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Targeting adenosine A2A receptors in Parkinson's disease
Michael A. Schwarzschild et al.
TRENDS IN NEUROSCIENCES (2006)
3-[5-(4,5-dihydro-1H-imidazol-2-yl)-furan-2-yl]phenylamine (amifuraline), a promising reversible and selective peripheral MAO-A Inhibitor
Francesco Gentili et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines:: High affinity and selective A2B adenosine receptor antagonists
Rao V. Kalla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC)
N Vlok et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats
Y Xu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors
R Di Santo et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease
MBH Youdim et al.
NEUROLOGY (2004)
Inhibition of monoamine oxidase B by selective adenosine A2A receptor antagonists
JP Petzer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Why (-)deprenyl prolongs survivals of experimental animals: Increase of anti-oxidant enzymes in brain and other body tissues as well as mobilization of various humoral factors may lead to systemic anti-aging effects
K Kitani et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2002)
Adenosine A2A receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats
K Koga et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2000)
Share Paper
